The Orbera gastric balloon is a non-surgical, temporary weight-loss device placed in the stomach to reduce food intake. The balloon is inflated and left in place for six months. During that time, patients follow a strict diet and exercise regimen to lose weight. It’s a popular choice for patients who want to avoid invasive surgery.

A sleeve diet plan involves gradual dietary progression after surgery, focusing on protein-rich foods, minimal carbohydrates, and small portion sizes. Long-term, patients must continue eating nutrient-dense, low-calorie meals to maintain weight loss. Key components include lean meats, vegetables, whole grains, and avoiding sugary and fatty foods.

Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

An abdominal tumor is any abnormal growth located within the abdomen. Tumors can originate from the stomach, intestines, liver, or other abdominal organs. They can be benign or malignant, and treatment often involves surgery, chemotherapy, or radiation therapy, depending on the tumor's size, type, and stage.

The cost of a gastric sleeve in Antalya generally ranges from £2,500 to £4,500, depending on the clinic and any additional services included. This price is considerably lower than in the UK, US, or Europe, making Antalya a top choice for medical tourists.

Gastritis can sometimes cause referred pain that radiates to the back, although this is not a common symptom. If a patient experiences back pain along with gastritis symptoms like nausea, bloating, or indigestion, it could indicate a more severe condition or complications such as ulcers.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

Gastric bypass surgery typically costs between £10,000 and £15,000 in private clinics in the UK. This surgery is a popular option for long-term weight loss and involves creating a small stomach pouch and rerouting the intestines to limit food intake and absorption.

A gastro appointment is a consultation with a gastroenterologist. During this visit, the doctor assesses symptoms like stomach pain, acid reflux, or changes in bowel habits. The appointment might involve a physical exam, blood tests, or diagnostic procedures like an endoscopy or colonoscopy to identify the issue.

The cost of Roux-en-Y (RNY) gastric bypass surgery varies widely depending on the country, hospital, and insurance coverage. In the U.S., it typically ranges between $20,000 and $30,000. In the UK, the procedure may be covered by the NHS if the patient meets specific criteria, or it can be done privately for £8,000 to £15,000.

Sleeve surgery is another term for the gastric sleeve procedure, where most of the stomach is removed to help patients achieve significant weight loss. The procedure is less invasive than other forms of bariatric surgery, like the Roux-en-Y bypass, but still offers dramatic weight-loss results.

A bowel specialist, or gastroenterologist, diagnoses and treats diseases of the digestive tract, including the stomach, intestines, and colon. Common conditions treated include IBS, Crohn’s disease, ulcerative colitis, and colon cancer.

Weight-loss injections like Saxenda or Wegovy are available in Turkey as part of weight management programs. These injections help control appetite and promote weight loss by regulating hunger hormones. They are often prescribed to patients with obesity or related health conditions who have not been successful with diet and exercise alone.

Patients typically need a Body Mass Index (BMI) of 35 or higher, with obesity-related health conditions, or a BMI of 40 or more to qualify for gastric sleeve surgery. This surgery, known as Vertical Sleeve Gastrectomy (VSG), involves removing about 80% of the stomach to reduce food intake and is one of the most popular bariatric procedures.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.